Literature DB >> 17420164

Time trends of mortality from Crohn's disease and ulcerative colitis.

Amnon Sonnenberg1.   

Abstract

AIMS: The present study served to test whether Crohn's disease and ulcerative colitis showed similarities in the temporal variation of their mortality rates among different countries.
METHODS: Mortality data from 21 different countries between 1951 and 2005 were analysed, including Argentina, Australia, Austria, Belgium, Canada, Chile, Denmark, England, Finland, France, Germany, Italy, Japan, Mexico, Netherlands, Scotland, Spain, Sweden, Switzerland, Taiwan and USA. The age-specific death rates of each individual country, as well as the average age-specific rates of all countries, were plotted against the period of death.
RESULTS: Death rates from ulcerative colitis were initially 6-fold higher than those of Crohn's disease. Mortality from ulcerative colitis decreased continuously during the past 50 years. Mortality from Crohn's disease increased from 1951 to 1975 until reaching a similar level as mortality from ulcerative colitis. Since then the death rates of both diseases have followed a parallel time course. A same type of behaviour was found in the time trends of each individual age-group. The data from most countries revealed similar temporal patterns.
CONCLUSIONS: The relationships between the temporal changes of mortality from Crohn's disease and ulcerative colitis might suggest the presence of one primary risk factor responsible for the occurrence of both diseases, and at the existence of one additional secondary risk factor, responsible for the expression of Crohn's disease alone.

Entities:  

Mesh:

Year:  2007        PMID: 17420164     DOI: 10.1093/ije/dym034

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  8 in total

1.  Management of severe ulcerative colitis.

Authors:  Neeraj Narula; Bindia Jharap; Jean-Frederic Colombel
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

Review 2.  Steroid-refractory severe ulcerative colitis: what are the available treatment options?

Authors:  Alan C Moss; Mark A Peppercorn
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Hospitalizations for inflammatory bowel disease among US military veterans 1975-2006.

Authors:  Amnon Sonnenberg; Peter A Richardson; Neena S Abraham
Journal:  Dig Dis Sci       Date:  2009-03-04       Impact factor: 3.199

4.  Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: the inflammatory bowel disease model.

Authors:  Andrew Szilagyi; Henry Leighton; Barry Burstein; Xiaoqing Xue
Journal:  Clin Epidemiol       Date:  2014-05-27       Impact factor: 4.790

Review 5.  Second Korean guidelines for the management of ulcerative colitis.

Authors:  Chang Hwan Choi; Won Moon; You Sun Kim; Eun Soo Kim; Bo-In Lee; Yunho Jung; Yong Sik Yoon; Heeyoung Lee; Dong Il Park; Dong Soo Han
Journal:  Intest Res       Date:  2017-01-31

Review 6.  Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians.

Authors:  Konstantina Rosiou; Christian Philipp Selinger
Journal:  Intern Emerg Med       Date:  2021-03-22       Impact factor: 3.397

7.  Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study.

Authors:  Wei-Chen Lin; Meng-Tzu Weng; Chien-Chih Tung; Yuan-Ting Chang; Yew-Loong Leong; Yu-Ting Wang; Horng-Yuan Wang; Jau-Min Wong; Shu-Chen Wei
Journal:  J Transl Med       Date:  2019-12-12       Impact factor: 5.531

8.  Hospitalizations and in-hospital mortality for inflammatory bowel disease in Brazil.

Authors:  Ana Luiza Vilar Guedes; Amanda Lopes Lorentz; Larissa Fernandes de Almeida Rios Rios; Beatriz Camara Freitas; Adriano Gutemberg Neves Dias; Ana Luísa Eckhard Uhlein; Felipe Oliveira Vieira Neto; Jobson Felipe Soares Jesus; Túlio de Sá Novaes Torres; Raquel Rocha; Vitor D Andrade; Genoile Oliveira Santana
Journal:  World J Gastrointest Pharmacol Ther       Date:  2022-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.